2 results
01/Oct/2015
DOI: 10.1590/S1679-45082015AO3321
ABSTRACT Objective To assess the bone health status of children with cerebral palsy and the therapeutic effect of denosumab in a subgroup of children with cerebral palsy and decreased bone mass. Methods Children with cerebral palsy were evaluated according to their motor disability score (classification system gross motor functions III to V), bone density and bone turnover markers. Dual X-ray energy absorption was used to measure the lumbar spine, and total body, except the head. Thereafter a group of children […]
Keywords: Antibodies, monoclonal/therapeutic use; Cerebral palsy/drug therapy; Child; Osteoporosis/drug therapy
01/Jan/2014
01/Jan/2014
DOI: 10.1590/S1679-45082014AO2706
Objective : To report the experience in three Brazilian institutions with the use of rituximab in patients with different clinical forms of lupus erythematosus systemic in activity. Methods : The study consisted of a sample of 17 patients with LES, who were already being treated, but that at some stage of the disease showed refractory symptoms. The patients were subdivided into groups according to the clinical manifestation, and the responses for the use of rituximab were rated as complete, partial […]
Keywords: Antibodies, monoclonal/therapeutic use; Lupus erythematosus, systemic/drug therapy